Table 1.
Patient demographics and tumor characteristics.
| Items | Neoadjuvant group (n = 23) |
Adjuvant group (n = 35) |
P value∗ |
|---|---|---|---|
| Median age (yr) (range) | 58 (34–79) | 57 (31–80) | 0.760 |
| Gender: n (%) | |||
| Male | 15 (65.2) | 22 (62.9) | 0.855 |
| Female | 8 (34.8) | 13 (37.1) | |
| Anatomic location: n (%) | |||
| Proximal | 4 (17.4) | 3 (8.6) | 0.490 |
| Body | 7 (30.4) | 9 (25.7) | |
| Distal | 12 (52.2) | 23 (65.7) | |
| Tumor grade: n (%) | |||
| Well/moderately differentiated | 6 (26.1) | 8 (22.8) | 0.701 |
| Poorly differentiated | 11 (47.8) | 20 (57.1) | |
| Mucinous/signet ring cell cancer | 4 (17.4) | 6 (17.2) | |
| Others | 2 (8.7) | 1 (2.9) | |
| Pretreatment clinical T-stage (CT): n (%) | |||
| Stage 3 | 17 (73.9) | 28 (80.0) | 0.587 |
| Stage 4 | 6 (26.1) | 7 (20.0) |
*Comparisons for categorical variables performed using chi-square test.